Tertiary Minerals #TYM – Director Dealing, Issue of Equity and Total Voting Rights

Tertiary Minerals plc, the AIM traded company building a multi-commodity project portfolio announces that pursuant to terms agreed on 30 April 2014 and further to the RNS dated 20 August 2014, a non-executive director of the Company will be receiving settlement of a portion of his outstanding fees in ordinary shares of 0.01 pence each […]

Tertiary Minerals #TYM – TR1 Holdings in Company

 TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: Tertiary Minerals PLC 1b. Please indicate if the issuer is a […]

Tertiary Minerals #TYM – Total Voting Rights

Tertiary Minerals plc announces that in accordance with Financial Conduct Authority’s Disclosure and Transparency Rules (“DTRs”), the total issued share capital of the Company with voting rights as at the date of this notice is  633,433,448 ordinary shares. There are no shares currently held in treasury. The total number of voting rights in the Company as at the […]

PBOC Easing Boosts Gold Price & Investment Case for Junior Gold Explorers

Investors seeking to capitalise on a bullish gold market in 2020, and in particular the next raft of discoveries, will no doubt be aware of the impact that the easing in monetary policy by the Peoples Bank of China (PBOC) has had across markets in China, still reeling from the CoronaVirus. With the yellow metal […]

Open Orphan #ORPH – Appointment of new Director

Open Orphan , the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services , is pleased to announce, further to its announcement of 13 February 2020, the appointment to the board of Leo Toole as Chief Financial […]

Open Orphan #ORPH – Result of Rule 15 Offer and Total Voting Rights

Open Orphan , the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs , announces, further to its announcement of 7 January 2020, the results of the Rule 15 Offer previously issued to the holders of options in hVIVO. Under the Rule 15 offer (the “Rule 15 Offer”), 4 hVIVO option holders […]

Mirriad #MIRI – Technology Showcase Event Video

Mirriad #MIRI – Technology Showcase Event Video – We’re hugely proud of our technology, and we were delighted to have the chance to show it off to investors and analysts at our showcase event in London.